Intervention Study on Medication Reconciliation Among Pharmacists in Two Tertiary Hospitals in Nigeria
NCT ID: NCT03182972
Last Updated: 2022-11-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1000 participants
INTERVENTIONAL
2016-08-02
2019-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Medication Reconciliation Intervention on the Rate of Preventable Adverse Drug Events (ADEs) and Healthcare Utilization
NCT02805270
Implementation of a Pharmacy-Intervention to Enhance Prescription and Use of Lipid-Lowering Drugs
NCT00509717
Communication Between Hospital and Community Pharmacists: Impact on Drug Management at Discharge
NCT02006797
Impact of Pharmacists Directed Medication Reconciliation on Reducing Medication Discrepancies in a Surgery Ward
NCT03928106
Medication Reconciliation in Comparison to an Extensive Medication Safety Check
NCT02413957
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Intervention will be channeled towards addressing gaps discovered. University College Hospital, Ibadan, Oyo State will be the intervention group, while University of Ilorin Teaching Hospital, Kwara State will be the control group.
The effect of the intervention will be measured over time to ensure that medication reconciliation is implemented in the selected institutions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention arm
Seminar presentation will be done using the followings:
1. Power point presentation on the following topics as it relates to medication reconciliation:
1. Communication skill (with patients and also with other members of the healthcare team)
2. Documentation of pharmaceutical care activities
3. Medication history taking
4. Drug therapy problems
5. Medication reconciliation practice
2. Case studies on medication reconciliation
3. Role plays on medication reconciliation
Medication reconciliation
Pre-post intervention
Control arm
Control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medication reconciliation
Pre-post intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Registered pharmacists in the selected institutions
Exclusion Criteria
* Unregistered pharmacists in the selected institutions
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Ibadan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AKINNIYI AKINBIYI AJE
Lecturer II
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
TITILAYO O FAKEYE, PhD
Role: STUDY_DIRECTOR
University of Ibadan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Ilorin Teaching Hospital
Ilorin, Kwara State, Nigeria
University College Hospital
Ibadan, Oyo State, Nigeria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MR/UCH/FMC/73247
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.